The ePATH Catheter Kit and Display are CE Marked and will be followed by the ePATH endoAVF system.

Our patented platform catheter technology can address multiple markets including peripheral bypass procedures, structural heart, and coronary applications.

Current Market Opportunities

CTO Re-entry
device
£108m
2020
Minimally invasive
bypass
£854m
2020
Minimally invasive 

AVF creation
£2.9b
2020

The ePATH platform catheter technology can address multiple markets including peripheral and coronary bypass procedures, structural heart, and endovascular aneurysm repair.

Market Data for endoAVF Creation:

EUROPE
Addressable Market
£450m
Growth Rate
2%
USA
Addressable Market
£1.654b
Growth Rate
3.5%
JAPAN
Addressable Market
£481m
Growth Rate
2%
CHINA
Addressable Market
£382m
Growth Rate
10%